Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

NCT07191834 is registered in ClinicalTrials.gov with Wuhan Pulmonary Hospital as lead sponsor.

NCT NCT07191834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis
Lead sponsor
Wuhan Pulmonary Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 30, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pretomanid, rifampicin-resistant/multidrug-resistant pulmonary tuberculosis, type 2 diabetes mellitus (t2dm)